Changes in type II cell populations in monocrotaline pneumotoxicity

Area of Science:

• Pulmonary toxicology
• Cell biology
• Respiratory pathology

Background:

• Systemic pneumotoxicants typically induce a proliferative type II cell response.
• Monocrotaline (MCT) is a pneumotoxicant known not to elicit this proliferative response.

Purpose of the Study:

• To investigate the effect of Monocrotaline (MCT) on type II alveolar epithelial cells.
• To determine if MCT alters the numerical density and volume of type II cells in rat lungs.

Main Methods:

• Utilized morphometric analysis of electron micrographs from MCT-treated and control rat lungs.
• Calculated average cell volume and numerical density of type II cells using point and intercept counts.
• Determined areal densities of type II cell profiles via light microscopy.

Main Results:

• MCT treatment caused a marked increase in type II cell volume (1.25 x 10^3 µm³ vs. 3.4 x 10² µm³).
• Nuclear diameter of type II cells was significantly larger in MCT-treated rats (8.53 µm vs. 5.81 µm).
• Numerical density of type II cells decreased significantly in MCT-treated rats (1.36 x 10⁶ cells/cm³ vs. 7.65 x 10⁶ cells/cm³).

Conclusions:

• Monocrotaline (MCT) induces significant cellular hypertrophy of type II alveolar epithelial cells.
• This hypertrophy is linked to a failure in maintaining normal type II cell populations in MCT-treated rat lungs.
• Hypothesized that MCT-induced changes are analogous to liver hypertrophy and mitotic inhibition seen with hepatotoxic pyrrolizidine alkaloids.